I aim to investigate the neural mechanisms underlying Parkinson’s disease, with a particular focus on MRI-based biomarkers for disease progression and subtype differentiation. My research interests lie in leveraging advanced MRI-based neuroimaging along with supporting biological, clinical and psychiatric data to holistically explore structural and functional alterations in patients with early- moderate- and late-stage Parkinson's Disease, aiming to improve early diagnosis and personalized treatment strategies.